Nano-Formulated Apelin13 Reduces Cerebral Ischemia/Reperfusion Injury in Rats by Suppressing Activity of TLR4/MyD88/NF-кB Axis and Pro-inflammatory Cytokines; an Experimental Study.
Archives of Academic Emergency Medicine · 01.01.2026 · 14 (1) · e29-e29
DOI: 10.22037/aaem.v14i1.2941 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Academic Emergency Medicine, erschienen am 01.01.2026. Verfasst von Elham Kashafi Jahromi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Nanocarrier-mediated delivery represents a promising strategy for enhancing the therapeutic efficacy of pharmacological agents. This study investigated whether encapsulating the endogenous peptide apelin-13 in niosomes (Nano-Apelin13) could improve its protective effects against ischemic stroke injury in rats.
Methods
Transient focal cerebral ischemia was induced by 60-minute middle cerebral artery occlusion (MCAO) followed by 24-hour reperfusion. Sixty rats were randomly allocated into five experimental groups: Sham, CI/R (ischemia/reperfusion), CI/R + empty niosomes, CI/R + free Apelin13, and CI/R + Nano-Apelin13. Free Apelin13 and Nano-Apelin13 (40 µg/kg) were administered intravenously 1 hour after reperfusion onset. After 24 hours, cerebral infarction size, neurological deficit scores, brain water content, and neuronal damage were evaluated. Protein expression levels of TLR4, MyD88, NF-κB, TNF-α, and IL-1β were analyzed by western blotting.
Results
Both free Apelin13 and Nano-Apelin13 significantly reduced cerebral infarct volume, improved neurological scores, decreased neuronal loss, and downregulated MyD88 and NF-κB expression. However, Nano-Apelin13 demonstrated superior efficacy, normalizing several parameters to sham-operated levels. Notably, Nano-Apelin13 significantly suppressed TLR4 expression and attenuated cerebral edema and pro-inflammatory cytokine production, effects that were either significantly enhanced or absent in the free Apelin13-treated group.
Conclusion
Delivery of Apelin13 in niosomes could be a good option to reduce CI/R damage by inhibiting the activity of TLR4/MyD88/NF-kB axis compared to free Apelin13.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
- Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein 2028, South Africa.
Zitieren
APA
Kashafi Jahromi, E., Nasseri Maleki, S., Hamblin, M. R., Ramezani, F., & Aboutaleb, N. (2026). Nano-Formulated Apelin13 Reduces Cerebral Ischemia/Reperfusion Injury in Rats by Suppressing Activity of TLR4/MyD88/NF-кB Axis and Pro-inflammatory Cytokines; an Experimental Study. Archives of Academic Emergency Medicine, 14(1), e29-e29. https://doi.org/10.22037/aaem.v14i1.2941
Vancouver
Kashafi Jahromi E, Nasseri Maleki S, Hamblin MR, Ramezani F, Aboutaleb N. Nano-Formulated Apelin13 Reduces Cerebral Ischemia/Reperfusion Injury in Rats by Suppressing Activity of TLR4/MyD88/NF-кB Axis and Pro-inflammatory Cytokines; an Experimental Study. Archives of Academic Emergency Medicine. 2026;14(1):e29-e29. doi:10.22037/aaem.v14i1.2941
BibTeX
@article{KashafiJahromi2026,
author = {Kashafi Jahromi, Elham and Nasseri Maleki, Solmaz and Hamblin, Michael R and Ramezani, Fatemeh and Aboutaleb, Nahid},
title = {Nano-Formulated Apelin13 Reduces Cerebral Ischemia/Reperfusion Injury in Rats by Suppressing Activity of TLR4/MyD88/NF-кB Axis and Pro-inflammatory Cytokines; an Experimental Study},
journal = {Archives of Academic Emergency Medicine},
year = {2026},
volume = {14},
number = {1},
pages = {e29--e29},
doi = {10.22037/aaem.v14i1.2941}
}
EUVIMED